Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

425.57 +5.68 (+1.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,499,269
Open 416.28
Bid (Size) 423.00 (1)
Ask (Size) 426.00 (1)
Prev. Close 419.89
Today's Range 415.76 - 426.96
52wk Range 362.50 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks
Via MarketBeat
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
 
Via Benzinga

Performance

YTD
+4.9%
+4.9%
1 Month
+5.3%
+5.3%
3 Month
-7.9%
-7.9%
6 Month
-15.1%
-15.1%
1 Year
-10.6%
-10.6%

More News

Read More
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup
Via Chartmill
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
Via The Motley Fool
Vertex to Participate in the UBS Global Healthcare Conference on November 11
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
Via The Motley Fool
Topics Intellectual Property
The Best Stocks to Invest $50,000 In Right Now
Via The Motley Fool
Topics Artificial Intelligence Energy
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study
Via Chartmill
2 Growth Stocks to Invest $1,000 in Right Now
Via The Motley Fool
Topics Artificial Intelligence World Trade
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
From Vertex Pharmaceuticals Incorporated
Via Business Wire
2 Soaring Cathie Wood Stocks to Buy and Hold
Via The Motley Fool
Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market
Via Benzinga
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Offers Affordable Growth in Biotech
Via Chartmill
2 Unstoppable Growth Stocks to Buy During a Market Crash
Via The Motley Fool
Topics Government Stocks World Trade
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
Via Benzinga
4 Healthcare Stocks to Buy Now
Via The Motley Fool
Topics Artificial Intelligence
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Via Benzinga
The Smartest Growth Stock to Buy With $500 Right Now
Via The Motley Fool
Topics Economy
Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?
Via StockStory
Topics Stocks
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
Via The Motley Fool
Topics Government Stocks World Trade
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
Via Benzinga
1 Healthcare Stock with Exciting Potential and 2 Facing Challenges
Via StockStory
Topics Stocks
2 Beaten-Down Stocks Primed for a Comeback
Via The Motley Fool

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 425.57
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 10/31/25 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 110.40B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 110B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.